Single agent umbralisib effective for relapsed slow-growing lymphoma
MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer ...
MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer ...
Obstructive sleep apnea and short sleep duration have distinct clinical impacts; clinicians should avoid a 'one-size-fits-all' approach through proper diagnosis ...
Circulation Journal Report DALLAS, April 1, 2019 -- A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander ...
Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live ...
FAIR Health market indices and trending reports once again bring valuable visibility into patient migratory patterns and healthcare costs NEW ...
Credit: © 2019 AANS CHARLOTTESVILLE, VA (APRIL 1, 2019). The April issue of Neurosurgical Focus (thejns.org/toc/foc/46/4) contains 15 new articles ...
All brisk walking, even short walks, help prevent disability in older adults with osteoarthritis CHICAGO --- Just one hour a ...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (April 1, 2019) - When a breast cancer tumor is removed ...
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) ...
Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy ...
ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at ...
Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA - ...
Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to ...
ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who ...
ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among ...
ATLANTA -- A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was ...
ATLANTA -- A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major toxicity ...
ORLANDO, Fla., March 31, 2019 -- As current antibiotics dwindle in effectiveness against multidrug-resistant pathogens, researchers are seeking potential replacements ...
A Columbia-led study finds adversity-induced disruptions in the body's gut microbes influence are linked to changes in brain function A ...
Credit: Mount Sinai Health System The Mount Sinai Health System (MSHS) and the Hasso Plattner Institute (HPI) today announced an ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.